News from all angles
(MedPage Today) -- DENVER -- Daily low-dose aspirin did not significantly reduce major vascular events in adults with chronic kidney disease (CKD), the randomized ATTACK trial showed. Over a mean fol…
Redirecting to MedPage Today in 3 seconds...
Share this story with your network